New York, May 08, 2018: The Global Radiotherapy Market is expected to exceed more than US$ 8.53 Billion by 2022 at a CAGR of 6.8% in the given forecast period.

    Every day new innovations are been made in every field and in healthcare lot of research and development is going on but for cancer till date radiotherapy is considered as most effective treatment overall for killing the cancer disease. A Cancer patient who uses beams of high energy radiation to kill cancer cells in the body is known as radiotherapy treatment. Radiotherapy is infrequently used to treat mild tumors and different conditions, for example, thyroid ailment and some blood disorders. Radiotherapy is utilized alone or in mix with chemotherapy (chemo radiotherapy) to treat cancer tumor. Symptoms of cancer can be effectively controlled by radiotherapy. Radiotherapy might be utilized before surgery or after surgery to decimate small tumor cells that might be cleared out.

    The Global Radiotherapy Market is segmented on the lines of its technology, product, application and regional. Based on technology segmentation it covers external beam radiation therapy, internal beam radiotherapy, systemic radiation therapy. Based on product segmentation it covers internal radiation therapy/brachy therapy, external beam radiation therapy, systemic radiation therapy. Based on application segmentation it covers external beam radiation therapy, internal radiation therapy.

    You Can Browse Full Report: 

    The Global Radiotherapy Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    The major driving factors of Global Radiotherapy Market are as follows:

    • Growing number of cancer patients and disease.
    • Technological innovations
    • Adoption of Radiotherapy Devices and Procedures are in raise
    • Driving Investments in Radiotherapy due to increase in demand for cancer treatment
    • Rapidly growing geriatric population
    • Spreading Awareness About the Benefits of Radiotherapy

    The restraining factors of Global Radiotherapy Market are as follows:

    • Absence of  adequate infrastructure
    • Visualizing Tumors is complex
    • Trained personnel shortage
    • Strict rules and regulations regarding healthcare

    This report provides:

    1) An overview of the global market for Global Radiotherapy Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Global Radiotherapy Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.


    The scope of the report includes a detailed study of global and regional markets on Global Radiotherapy Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Accuray Incorporated (U.S.), Ion Beam Applications SA (Belgium), C. R. Bard, Inc. (U.S.), IsoRay Medical, Inc. (U.S.), Varian Medical Systems, Inc. (U.S.), Nordion, Inc. (Canada), Elekta AB (Sweden), RaySearch Laboratories AB (Sweden), Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation (Japan).Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    Buy Full Research Report: 



    Table of Contents


    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    5.1 Introduction
    5.2 Market Segmentation
    5.2.1 Radiotherapy Market, By Product
    5.2.2 Radiotherapy Market, By Technology
    5.2.3 Radiotherapy Market, By Application
    5.3 Market Dynamics
    5.3.1 Drivers Technological Advancements Growing Number of Cancer Patients Rapidly Increasing Aging Population Rising Adoption of Radiotherapy Devices and Procedures Increasing Number of Symposiums Spreading Awareness About the Benefits of Radiotherapy
    5.3.2 Restraints Lack of Adequate Infrastructure & Healthcare Expenditure Shortage of Trained Personnel Unfavourable Healthcare Reforms in the United States
    5.3.3 Opportunities Emerging Markets Offer Numerous Growth Opportunities Increasing Demand for Cancer Treatment Driving Investments in Radiotherapy
    5.3.4 Challenges Difficulty in Visualizing Tumors Affordability and Accessibility of Treatment

    6 Radiotherapy Market, By Product

    7 Radiotherapy Market, By Technology

    8 Global Radiotherapy Market, By Application

    9 Radiotherapy Market, By Region

    10 Competitive Landscape

    11 Company Profiles

    11.1 Varian Medical Systems, Inc.

    11.2 Elekta AB

    11.3 Accuray Incorporated

    11.4 IBA (ION Beam Applications SA)

    11.5 Nordion, Inc.

    11.6 C. R. Bard, Inc.

    11.7 Isoray Medical, Inc.

    11.8 Raysearch Laboratories

    11.9 Mitsubishi Electric Corporation

    11.10 Mevion Medical Systems, Inc.

    11.11 Theragenics Corporation

    11.12 P-Cure Ltd.

    11.13 Viewray Inc.

    11.14 Panacea Medical Technologies Pvt. Ltd.

    11.15 Pronova Solutions, LLC.


    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay


    Phone: +1-855-984-1862

    Country: United States